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AbStRACt We present a case of 3-year-old Caucasian boy who devel-
oped monthly cyclic attacks of skin peeling of the palms and soles over 1.5 
years. The skin peeling was associated with hypercalciuria. No mutation 
was present in TGM5 and CSTA genes, but the typical clinical picture and 
the biopsy from flaccid blisters on the feet confirmed the acral peeling 
skin syndrome (APSS). The possible associations of rare genetic disorders 
and metabolic conditions in the course of APSS need to be investigated.
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IntRoduCtIon
The first description of peeling skin syndrome 
(PSS) in a 28-year-old woman was presented in 1921 
by Fox (1). The cases of PSS are divided into two 
types: generalized PSS and acral PSS (APSS). The ac-
ral peeling skin syndrome (APSS) is characterized by 
a painless spontaneous exfoliation of a subcorneal or 
intracorneal level of the skin of the dorsal and volar 
surface of the hands (2). Previous studies reported 
that there are usually no systemic abnormalities asso-
ciated with this syndrome (2,3). However, recently the 
possible co-occurrence of PSS with some metabolic 
abnormalities was reported, such as aminoaciduria, 
lowered tryptophan levels, elevated serum copper, 
cerulosplasmin, and abnormal vitamin A metabolism 
(4,5,6).
Here we present a case report of boy with APSS 
associated with hypercalciuria. 
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CASe PReSentAtIon 
The patient, a 3-year-old Caucasian boy of healthy, 
unrelated parents was admitted because the parents 
had been noticing a reoccurrence of the following 
symptoms every 3-4 weeks for the last 1.5 years: ery-
thema of the palms and soles followed by increased 
keratosis and then flaking of the epidermis. There was 
neither an associated pain nor pruritus. The patient 
presented with excessive sweating and foul smelling 
of feet. Polyuria with urine turbidity appeared on the 
same day, prior to skin lesions. Three months earlier, 
the child was diagnosed in the Clinic of Paediatric 
Nephrology with idiopathic hypercalciuria (calciuria 
greater than 4 mg/kg per 24 hours, elevated total 
calcium/creatinine ratio in a spot urine sample) with 
normal concentration values of serum calcium, phos-
phor, alkaline phosphatase (ALP), parathyroid hor-
mone (PTH), total thyroxine (T4), thyroid-stimulating 
hormone (TSH), and 1.25-dihydroxyvitamin D. The 
rest of his past medical and family history was unre-
markable.
The physical examination of the boy at admission 
revealed a good general appearance with normal de-
velopment. A bilateral and symmetrical peeling of the 
hands and the feet, worse on the palmar and plantar 
areas, was noted (Figure 1, Figure 2). The other areas 
of the skin were soft and pink. The teeth, the hair, and 
the nails were normal.
Hematological and biochemical investigations 
found normal values: complete blood count, eryth-
rocyte sedimentation rate (ESR), C-reactive protein 
(CRP), serum calcium, magnesium, ALP, iron, total 
iron binding capacity (TIBC), ferritin, T4, TSH, PTH, 
1.25-dihydroxyvitamin D, copper, ceruloplasmin, and 
total immunoglobulin E (IgE). Antinuclear antibodies 
(ANA) test was negative. Urine test parameters were 
normal. Microbiological tests from the mouth, nose, 
and stool were negative. We did not find any abnor-
malities in the chest X-ray, electrocardiogram (ECG), 
or abdominal ultrasonography.
On the 3rd day after admission the boy’s urine was 
clouded and the urine sediment showed crystals of 
calcium oxalate dehydrate. On the same day, peeling 
from the palms and soles started as well. 
Skin biopsy revealed acanthosis and compact or-
thohyperkeratosis with separation of the stratum cor-
neum from the underlying stratum granulosum and 
within the stratum corneum. In the dermis, sparse 
perivascular lymphocytes were present (Figure 3).
DNA analysis of TGM5 and CSTA genes were per-
formed and revealed no mutation in the tested genes Figure 1. Acral peeling skin syndrome on the hand.
table 1. Energy and selected nutrient intake  
of the patient (3-days record)
Energy and nutrients Intake per day % RDA*
Energy (kcal) 1320.9±187.1 132.1±18.7**
Water (g) 1622.4±105.4 124.8±8.1**
Total protein (g) 26.2±4.7 187.4±33.6
Fat (g) 42.2±13.1 108.2±33.7**
Total carbohydrates (g) 218.4±40.8 -
Sodium (mg) 1670.4±522.5 222.7±69.7***
Potassium (mg) 1595.6±548.4 66.5±22.9***
Calcium (mg) 243.6±88.2 48.7±17.6***
Phosphorus (mg) 539.6±57.2 117.3±12.4
Magnesium (mg) 173.4±34.9 216.8±43.6
Iron (mg) 5.7±2.4 81.4±34.8
Zinc (mg) 4.19±1.1 139.7±38.0
Cu (mg) 0.65±0.19 215.7±62.6
J (µg) 82.4±15.3 92.2±17.0
Vitamin A (µg) 1499.8±1153.3 374.9±288.3
Vitamin E (mg) 5.8±0.9 97.0±15.6**
Thiamin (mg) 0.50±0.16 100.8±33.0
Riboflavin (mg) 0.59±0.09 117.6±18.7
Niacin (mg) 5.2±2.2 87.8±37.3
Vitamin B6 (mg) 0.79±0.29 157.6±48.3
Vitamin C (mg) 48.3±32.8 120.7±82.0
Folic acid (µg) 126.9±48.7 105.8±40.6**
Vitamin B12 (µg) 1.19±0.77 169.6±109.7**
Vitamin D (µg) 0.91±0.11 18.2±2.1***
*Recommended dietary allowances (RDA) dependent 
on age and sex
**% of estimated average requirement (EAR) depen-
dent on age and sex
***% of adequate intake (AI)
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(Sanger sequencing of coding regions and exon-in-
tron boundaries, primers sequences, and PCR condi-
tions available on request).  
Dietary intake was assessed during hospitaliza-
tion using 3-day food records by a trained dietician 
and analyzed by the Dieta 5.0 computer program 
(National Food and Nutrition Institute, Poland) (Ta-
ble 1). The diet analysis showed an excessive intake 
of protein (187% recommended dietary allowances, 
RDA), of which 36.4% was animal protein. Moreover, a 
high intake of sodium, magnesium, cooper, and vita-
min C was noted (223%, 217%, 216%, and 120% RDA, 
respectively). The intake of calcium, potassium (49%, 
67% adequate intake (AI), respectively), and vitamin 
D (18% RDA) was insufficient.
Parents were instructed to minimize immersion in 
water and to use antiperspirants and emollients. Ad-
ditionally, the parents were instructed to limit sodium 
and supplement potassium, calcium, and vitamin D 
in the diet. In result, the parent decided to introduce 
a lacto-ovo-vegetarian diet for the boy. Two-years fol-
low up revealed normal development and adequate 
nutritional status of the child. The observations con-
firmed that after few month of regular application of 
the lacto-ovo-vegetarian diet, hypercalciuria disap-
peared and the signs of recurrent peeling were mini-
mized.
dISCuSSIon
Peeling skin syndrome (PSS) is a name for a het-
erogenous group of dermatoses, which are all char-
acterized by spontaneous, recurrent peeling of the 
outer layers of epidermis (7). Burns et al suggest the 
main pathological mechanisms in APSS are premature 
corneodesmolysis or changes in cornified envelope 
cross-linking as a consequence of transglutaminase 
5-coding genes (TGM5) localized on chromosome 15 
(8). However, it has recently been proven that the ge-
netic background of APSS is heterogenic. Mutations 
in at least one other gene – CSTA (3q21.1) encoding 
cystatin A, the cysteine proteinase inhibitor involved 
in epidermis cohesion, may cause APSS (9). Skin le-
sions in APSS have a predilection for the palms and 
feet. Casuistic reports point to possible other lesion 
locations such as the face (10) and skin appendages 
(5).
The prevalence of APSS in the general popula-
tion is not known, and according to many authors it 
is an underrecognised dermatosis. APSS is present all 
over the world (7), while most of the reported APSS 
case series in the literature concern Middle Eastern 
patients (11,12). Some authors point out that the syn-
drome occurs more commonly in children of related 
parents (11-13). 
Peeling pathognomonic for APSS is limited to 
the stratum corneum and can be associated with its 
complete or partial separation (7). The presence of 
lesions in deeper layers of the epidermis, including 
the surface area of stratum granulosum, excludes the 
diagnosis of APSS and makes it crucial to differential 
diagnosis from epidermolysis bullosa, ichthyosis, and 
autoimmune bullous dermatosis (2,7).
In the presented case, the diagnosis was made 
on the basis of the typical clinical picture, typical 
course of disease, and histopathological test results. 
Since Sanger sequencing-based molecular analysis of 
TGM5 and CSTA genes did not reveal any mutations, 
Figure 3. Orthohyperkeratosis, acanthosis, and sepa-
ration of the stratum corneum from the underlying 
stratum granulosum, and within the stratum corne-
um (hematoxylin and eosin staining, 100× magnifi-
cation).
Figure 2. Acral peeling skin syndrome on the feet.
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it is highly probable that the case is a sporadic form 
of the APSS resulting from mutation in another gene, 
yet unlinked with the syndrome.  
 
Due to the possible co-occurrence of metabolic dis-
turbances, more diagnostic tests were carried out. In 
our case we observed that the occurrence of skin le-
sions is preceded by cloudy urine with hypercalciuria. 
Since both signs coincide, common pathogenesis 
should be considered, especially since the calcium 
metabolism disturbances are observed in skin condi-
tions with abnormal keratinisation (14,15). Hypercal-
ciuria is influenced significantly by diet (16). Analysis 
of the diet of our patient showed multiple risk fac-
tors that escalate hypercalciuria: insufficient intake 
of calcium and potassium and high intake of sodium, 
animal protein, and vitamin C. The use of a vegetarian 
diet and thereby the replacement of animal protein 
by plant, especially soy protein, and increase in the 
dietary potassium/sodium ratio resulted in improve-
ment of hypercalciuria in our patient (17).
The proposed treatments of APSS encompass 
emollients, topical and systemic corticosteroids, 
methotrexate, systemic retinoids, and ultraviolet B 
(UVB) light treatment (4,11), but none of these meth-
ods proved satisfactory. 
As far as we know, it is possible that we reported 
the first case of APSS associated with hypercalciuria.
ConSent
Written informed consent was obtained from the 
mother of the patient for publication of this report 
and images.
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